Cited In for PMID: 17393507

Year	Number of Results
2007	3
2008	7
2009	5
2010	6
2011	8
2012	5
2013	5
2014	1
2015	6
2016	6
2017	1
2019	2
2020	2
2021	3
2022	2
2023	2
2024	0

1

Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis.

Robertson H, Kirby JA, Yip WW, Jones DE, Burt AD. Robertson H, et al. Hepatology. 2007 Apr;45(4):977-81. doi: 10.1002/hep.21624. Hepatology. 2007. PMID: 17393507

2

Potential therapeutic target of EGF on bile duct ligation model and biliary atresia children.

Zheng Q, Li M, Chen L, Zhang C, Zhao Y, Liu G, Yang F, Zhan J. Zheng Q, et al. Pediatr Res. 2023 Oct;94(4):1297-1307. doi: 10.1038/s41390-023-02592-4. Epub 2023 May 3. Pediatr Res. 2023. PMID: 37138025

3

Post-Transplant Immunosuppression in Autoimmune Liver Disease.

Kelly C, Zen Y, Heneghan MA. Kelly C, et al. J Clin Exp Hepatol. 2023 Mar-Apr;13(2):350-359. doi: 10.1016/j.jceh.2022.07.002. Epub 2022 Jul 12. J Clin Exp Hepatol. 2023. PMID: 36950491 Free PMC article. Review.

4

Potentials of ketogenic diet against chronic kidney diseases: pharmacological insights and therapeutic prospects.

Kundu S, Hossain KS, Moni A, Zahan MS, Rahman MM, Uddin MJ. Kundu S, et al. Mol Biol Rep. 2022 Oct;49(10):9749-9758. doi: 10.1007/s11033-022-07460-8. Epub 2022 Apr 20. Mol Biol Rep. 2022. PMID: 35441940 Review.

5

Cholangiocyte Epithelial to Mesenchymal Transition (EMT) is a potential molecular mechanism driving ischemic cholangiopathy in liver transplantation.

Wickramaratne N, Li R, Tian T, Khoraki J, Kang HS, Chmielewski C, Maitland J, Liebrecht LK, Fyffe-Freil R, Lindell SL, Mangino MJ. Wickramaratne N, et al. PLoS One. 2021 Jul 7;16(7):e0246978. doi: 10.1371/journal.pone.0246978. eCollection 2021. PLoS One. 2021. PMID: 34234356 Free PMC article.

6

Cellular Mechanisms of Liver Fibrosis.

Acharya P, Chouhan K, Weiskirchen S, Weiskirchen R. Acharya P, et al. Front Pharmacol. 2021 May 6;12:671640. doi: 10.3389/fphar.2021.671640. eCollection 2021. Front Pharmacol. 2021. PMID: 34025430 Free PMC article. Review.

7

MicroRNA-34a Promotes EMT and Liver Fibrosis in Primary Biliary Cholangitis by Regulating TGF-β1/smad Pathway.

Pan Y, Wang J, He L, Zhang F. Pan Y, et al. J Immunol Res. 2021 Apr 23;2021:6890423. doi: 10.1155/2021/6890423. eCollection 2021. J Immunol Res. 2021. PMID: 33977112 Free PMC article.

8

The liver matrisome - looking beyond collagens.

Arteel GE, Naba A. Arteel GE, et al. JHEP Rep. 2020 Apr 18;2(4):100115. doi: 10.1016/j.jhepr.2020.100115. eCollection 2020 Aug. JHEP Rep. 2020. PMID: 32637906 Free PMC article. Review.

9

The Matrisome, Inflammation, and Liver Disease.

Dolin CE, Arteel GE. Dolin CE, et al. Semin Liver Dis. 2020 May;40(2):180-188. doi: 10.1055/s-0039-3402516. Epub 2020 Jan 7. Semin Liver Dis. 2020. PMID: 31910448 Free PMC article. Review.

10

Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets.

Sato K, Glaser S, Kennedy L, Liangpunsakul S, Meng F, Francis H, Alpini G. Sato K, et al. Expert Opin Ther Targets. 2019 Jun;23(6):461-472. doi: 10.1080/14728222.2019.1608950. Epub 2019 Apr 22. Expert Opin Ther Targets. 2019. PMID: 30990740 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

58 results

Results by year